Dr. Tarek Elrafei, DO

  • Bronx, NY
  • Hematologist and oncologist
NPI1467563296PAC ID0446142855
Medicare services, 2024
50,728
Medicare patients, 2024
378
Part D claims, 2024
2,057
Publications
16
Hospital affiliations
2
Practice address
2330 Eastchester Rd, Bronx, NY 10469-5930
Practice phone
Call (631) 751-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Port Jefferson Station Medical Oncology

Multi-specialty group site · Bronx, New York

See all 6 affiliations

Find Dr. Elrafei's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Tarek Elrafei is a hematologist and oncologist in Bronx, New York

Dr. Elrafei practices at Port Jefferson Station Medical Oncology in Bronx, New York.

Dr. Elrafei's NPI, 1467563296, was assigned on August 31, 2006. Dr. Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1995. Dr. Elrafei holds New York license 212011.

NPI and contact details
Medicare PAC ID
0446142855
NPI enumeration date
August 31, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(631) 751-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
57
Medical school graduation
1995

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Tarek Elrafei practices at Port Jefferson Station Medical Oncology in Bronx, New York

Dr. Elrafei's primary practice is Port Jefferson Station Medical Oncology, at 2330 Eastchester Rd, Bronx, NY 10469-5930. The practice phone is (631) 751-3000.

  • Port Jefferson Station Medical Oncology
    2330 Eastchester Rd, Bronx, NY 10469-5930Phone(631) 751-3000

Source: Dmand AI Affiliation Data

Dr. Tarek Elrafei is affiliated with 4 sites of care and 2 medical groups

Dr. Elrafei's primary practice is Port Jefferson Station Medical Oncology in Bronx, New York. Dr. Elrafei is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Harlem Medical Associates. Dmand AI also links Dr. Elrafei to 1 more hospital, 1 physician office and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Elrafei

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Tarek Elrafei's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elrafei practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Port Jefferson Station Medical OncologyAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Elrafei practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Tarek Elrafei is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Elrafei's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Elrafei is board certified in hematology by the American Board of Internal Medicine. Dr. Elrafei is licensed in New York.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 212011 · taxonomy 207RH0003X

Clinical focus

Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Elrafei treats.

Hematologists and oncologists near Dr. Elrafei

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Tarek Elrafei billed Medicare for 50,728 services in 2024

CMS data shows 50,728 Medicare services from Dr. Elrafei across 60 procedure codes in 2024, for 378 Medicare patients. Medicare paid $292,534 for them.

Medicare services, 202450,728
Medicare patients378
Paid by Medicare$292,534
Procedure codes60

Dr. Elrafei's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 16,4952024: 38,809135%
Lab and pathology
2023: 9,7592024: 9,3734%
Office and hospital visits
2023: 1,3292024: 1,15913%
Surgery
2023: 9322024: 9795%
Tests and treatments
2023: 4552024: 40810%
Other services
2023: 122024: 0100%

Where Dr. Elrafei's Medicare services took place, 2024

  • In an office50,672100%
  • In a facility560%

Dr. Elrafei compared with the New York median for hematologists and oncologists, 2024

  • Dr. Elrafei
  • New York median
Medicare services
50,728vs 66875.9 times
Medicare patients
378vs 21080% above
Part D claims
1,684vs 2586.5 times

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Elrafei's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Elrafei

Need commercial claims for Dr. Elrafei?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Elrafei and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Tarek Elrafei treated 378 Medicare patients in 2024, average age 75

CMS counts 378 Medicare patients who saw Dr. Elrafei in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elrafei's median patient age at 59, with 66% women.

Medicare patients, 2024378
Average age75
Average risk score2.02
Also on Medicaid29%

Dr. Elrafei's Medicare patients by age, 2024

Dr. Elrafei's Medicare patients by sex, 2024

  • Women23061%
  • Men14839%

Chronic conditions among Dr. Elrafei's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Diabetes52%
  4. Arthritis46%
  5. Cancer41%
  6. Chronic kidney disease40%
  7. Ischemic heart disease32%
  8. COPD23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Elrafei's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 59

Patient panel by sex, all payers

  • Women66%
  • Men31%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Tarek Elrafei wrote 2,057 Medicare Part D claims in 2024

In 2024, Dr. Elrafei wrote 2,057 Medicare Part D claims for 253 patients. CMS names the drug for 1,684 of them, across 56 drugs with 11 or more claims each, at $8,390,306 in total drug cost. In 2023, CMS named 1,135 claims across 41 drugs.

Part D claims, 20242,057
Drugs named by CMS56
Total drug cost$8.4M
Part D patients253

Dr. Elrafei's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Elrafei's Part D claims, 2024

  • Opioids2%49 of 2,057 claims
  • Antibiotics2%44 of 2,057 claims
  • Antipsychotics, patients 65 and over1%11 of 2,057 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,1352024: 1,68448%

Drugs named by CMS: 56 in 2024, 41 in 2023.

See all prescribing by Dr. Elrafei

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Tarek Elrafei offers telehealth to Medicare patients

Dr. Elrafei accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elrafei as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Elrafei by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Tarek Elrafei has 16 publications on record

Dmand AI links 16 papers to Dr. Elrafei, published from 2014 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Bone Marrow, Bone Marrow Examination and Ilium. Dr. Elrafei's most frequent co-authors are Marianna Strakhan, MD, Karenza Michelle Alexis, MD and Shirin Attarian, MD.

Papers16
Years published2014 to 2024

Dr. Elrafei's papers by year, 2014 to 2024

Topics Dr. Elrafei writes about most

  • Bone Marrow
  • Bone Marrow Examination
  • Ilium

Dr. Elrafei's most frequent co-authors

Recent publications by Dr. Elrafei

See all 16 publications and co-authors

See who Dr. Elrafei researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Elrafei works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Tarek Elrafei received $2,141 in industry payments from 2016 to 2025

CMS Open Payments shows 91 general payments to Dr. Elrafei from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Novartis Pharmaceuticals Corporation paid the most, $818.

General payments to Dr. Elrafei by program year, 2016 to 2025

General payments to Dr. Elrafei by kind, 2016 to 2025

$2.1Kin total
  • Food and beverage$1,04349%
  • Travel and lodging$81838%
  • Education$28013%

Companies that paid Dr. Elrafei the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Elrafei

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Tarek Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine

Dr. Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1995.

  1. Medical schoolDr. Kiran C. Patel College of Osteopathic Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine
  4. Board certified in 2000 - 2025NJ State License
  5. Board certified in 1998 - 2026NY State License

Source: Dmand AI Professional Profile Data

Dr. Tarek Elrafei accepts plans from 20 insurance carriers

Dr. Elrafei is in network with 20 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Plan types Dr. Elrafei accepts, by number of carriers

  1. PPO12
  2. Medicare10
  3. HMO8
  4. EPO5
  5. Medicaid3
  6. POS3

Source: Dmand AI Insurance Network Data

Sources for Dr. Tarek Elrafei's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Tarek Elrafei

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Tarek Elrafei's NPI number?

Dr. Tarek Elrafei's NPI number is 1467563296. It was assigned on August 31, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Tarek Elrafei?

Dr. Tarek Elrafei is a hematologist and oncologist in Bronx, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Tarek Elrafei practice?

Dr. Elrafei practices at 2330 Eastchester Rd, Bronx, NY 10469-5930. Dr. Elrafei's primary practice is Port Jefferson Station Medical Oncology in Bronx, New York. Dmand AI also links Dr. Elrafei to 1 hospital, 1 physician office and 1 medical group.

What is Dr. Tarek Elrafei's office phone number?

The practice phone on file for Dr. Elrafei is (631) 751-3000.

What is Dr. Tarek Elrafei's medical license number?

Dr. Elrafei holds New York license 212011.

Which hospitals is Dr. Tarek Elrafei affiliated with?

Dr. Elrafei is affiliated with Montefiore Einstein Hospital-Moses Campus. Dmand AI links Dr. Elrafei to 1 more hospital.

What medical group is Dr. Tarek Elrafei part of?

Dr. Elrafei is linked to Harlem Medical Associates. Dmand AI links Dr. Elrafei to 1 more medical group.

Does Dr. Tarek Elrafei accept Medicare?

Yes. CMS data shows Dr. Elrafei billed Medicare for 50,728 services in 2024, and Dr. Elrafei accepts Medicare assignment.

Does Dr. Tarek Elrafei offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Elrafei as offering telehealth services.

How many Medicare patients does Dr. Tarek Elrafei see?

CMS counts 378 Medicare patients who saw Dr. Elrafei in 2024, with an average age of 75.

Show 9 more questionsShow fewer questions

Is Dr. Tarek Elrafei board certified?

Yes. Dr. Elrafei is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Tarek Elrafei bill to Medicare?

In 2024, Dr. Elrafei's most billed Medicare services were injected or infused drug (J1439), lab and pathology test (88185) and surgery: heart and blood vessels (36415).

Where did Dr. Tarek Elrafei go to medical school?

Dr. Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1995.

What drugs does Dr. Tarek Elrafei prescribe most?

In 2024 Medicare Part D data, Dr. Elrafei's most prescribed drugs by claims were Aranesp, Procrit and Akynzeo.

Has Dr. Tarek Elrafei received payments from drug or device companies?

CMS Open Payments shows $2,141 in general payments to Dr. Elrafei from 20 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Tarek Elrafei been practicing?

Dr. Elrafei graduated from medical school in 1995, 31 years ago.

Does Dr. Tarek Elrafei do research?

Dmand AI links 16 publications to Dr. Elrafei, published from 2014 to 2024.

Who does Dr. Tarek Elrafei publish with?

Dr. Elrafei's most frequent co-authors are Marianna Strakhan, MD (5 shared papers), Karenza Michelle Alexis, MD (3 shared papers) and Shirin Attarian, MD (2 shared papers).

What insurance does Dr. Tarek Elrafei accept?

Dr. Elrafei is in network with 20 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)